CHEMOMAB THERAPEUTICS LTD
SPONSORED ADS · CUSIP 16385C104
13
institutional holders
+2 vs Q1 2021
3.1m
shares reported held*
$59.5mreported value*
6 new
1 added
4 reduced
4 sold out
net bought ≈ $4.7m (+249.4k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $19.02.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 11 |
| Q2 2021 | 13 |
Biggest buyers
| Ikarian Capital, LLC | New | +290.5k |
| MEITAV INVESTMENT HOUSE LTD | Added | +73.0k |
| MARSHALL WACE, LLP | New | +63.6k |
| Marshall Wace North America L.P. | New | +44.0k |
| Virtu Financial LLC | New | +13.2k |
| Spire Wealth Management | New | +500 |
| JPMORGAN CHASE & CO | New | +51 |
Biggest sellers
| Maven Securities LTD | Sold out | -126.6k |
| CVI Holdings, LLC | Sold out | -93.8k |
| BOOTHBAY FUND MANAGEMENT, LLC | Reduced | -7.0k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -7.0k |
| UBS Group AG | Reduced | -695 |
| MORGAN STANLEY | Reduced | -171 |
| Ironwood Financial, llc | Reduced | -160 |
| Tower Research Capital LLC (TRC) | Sold out | -76 |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 0.50% of their portfolio | 2.6m $49.0m | Unchanged |
| Ikarian Capital, LLC 0.99% of their portfolio | 290.5k $5.5m | New |
| MEITAV INVESTMENT HOUSE LTD 0.02% of their portfolio | 81.3k $1.5m | Added +73.0k |
| MARSHALL WACE, LLP 0.01% of their portfolio | 63.6k $1.2m | New |
| BOOTHBAY FUND MANAGEMENT, LLC 0.04% of their portfolio | 54.7k $1.0m | Reduced -7.0k |
| Marshall Wace North America L.P. 0.00% of their portfolio | 44.0k $837.0k | New |
| Virtu Financial LLC 0.02% of their portfolio | 13.2k $251.0k | New |
| Spire Wealth Management 0.00% of their portfolio | 500 $10.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 163 $3.0k | Reduced -171 |
| UBS Group AG 0.00% of their portfolio | 139 $3.0k | Reduced -695 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 51 $1.0k | New |
| Ironwood Financial, llc 0.00% of their portfolio | 7 $0 | Reduced -160 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |